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Background Findings Discussion
Postoperative sore throat (POST) is a common side effect from general 
anesthesia (GA) and has a prevalence of 14.4-50%.1 The experience of 
POST contributes to patient discomfort during recovery from surgery. The 
etiology of this is thought to be from tracheal mucosal erosion from the cuff 
of the endotracheal tube (ETT), trauma from intubation, coughing and 
bucking, and friction between the ETT and the tracheal mucosa during 
general anesthesia.2  Risk factors shown to contribute to the development 
of POST include, but are not limited to, elderly age, smoking history, 
patient positioning, ETT cuff pressure, and movement of ETT during 
procedure.2,3 The presence of POST after surgery can affect patient 
comfort during the post-operative recovery period and ultimately, impact 
patient satisfaction.
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Methods
• A retrospective, observational, EPB project was conducted at 
Providence Sacred Heart Medical Center and Providence Holy Family 
Hospitals. 
• CIRC approval and IRB exemption was obtained. 
• A HIPPAA compliant REDCap database was used to securely store 
deidentified extracted data. No PHI was collected. 
• The outcome of post-operative sore throat was assessed.
• Exposure to various modalities of intra-tracheal lidocaine was assessed. 
• Surgical patients undergoing elective general anesthesia with 
endotracheal tube from January 1 to December 31 of 2019 were 
included.  
• Exclusion criteria: Non-ETT general anesthesia with age <18
• An a-priori power analysis revealed 785 records would power results (1-
β=0.80, α=0.05, Df=1, W=0.1).
• Univariate analysis was done on categorical and continuous data.
• Bivariate analysis for POST and lidocaine was conducted and RR, CI, 
and chi-Square p-values were reported. 
• Binary logistic regression analysis was performed.
This retrospective observational EBP study shows that rates of POST 
among patients receiving GA with an ETT are 21% (n=318). Of the POST 
group, 81% did not receive any form of intratracheal lidocaine (n=282). The 
most common form of intratracheal lidocaine used was via laryngotracheal 
topical anesthesia (LTA). Limitations of this study include small sample size, 
limited and subjective reporting of POST, and inconsistent documentation of 
intratracheal lidocaine. Multiple studies support the use of intratracheal 
lidocaine to prevent the development of POST after general anesthesia with 
an ETT.1
This EBP project shows that there was a statistically insignificant reduction of 
POST with the use of 4% LTA. However, this study may generate hypothesis 
about LTA use, given limited research published on the use of LTA’s for POST. 
Lidocaine gel 2% showed statistically significant reduction in POST. Only one 
occurrence of intra-cuff lidocaine was documented, showing no reduction in 
POST, however there is strong research evidence showing the effectiveness 
of intra-cuff lidocaine on the reduction of POST.4 This study may inform further 
hypothesis about group characteristics of patients receiving intratracheal 
lidocaine. 
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* BMI: Body Mass Index; PSHMC: Providence Sacred Heart Medical Center; PHFH: Providence Holy 









Rates of POST with Intratracheal Lidocaine (n=60)
Rates of POST without Intratracheal Lidocaine (n=282)
* LTA: laryngotopical tracheal anesthesia; RR: Relative Risk; 95% Confidence Interval
Mean StDev Mean StDev P-Value
Age 54.38 17.29 56.00 17.12 0.14
BMI* 30.66 7.54 31.58 8.28 0.06
Case Duration 100.82 54.46 127.11 83.33 <0.05
Count Percent Count Percent P-Value
Facility
PSHMC* 711 47% 268 18% <0.05
PHFH* 471 31% 50 3%
Gender
Female 729 49% 189 13% 0.47
Male 453 30% 129 9%
Smoker 193 13% 39 3% 0.35
Videoscope 407 27% 121 8% 0.23
Multiple positions 308 21% 163 11% <0.05
IT lidocaine* 169 11% 60 4% 0.04
Paralytic 912 61% 293 20% <0.05
ETT Size*
6.5 17 1% 8 3% 0.18
7 447 38% 120 38% 0.98
7.5 205 17% 58 18% 0.71
8 195 16% 64 20% 0.13
8.5 6 1% 5 2% 0.05
Airway Attempts
1 1029 87% 272 86% 0.48
2 49 4% 13 4% 0.96
3 17 1% 5 2% 0.86
Table 1. Demographic and clinical characteristics (N =1500)
POST No (n =1182) POST Yes (n =318)
RR* 95% CI* P-Value
4% LTA 0.94 0.87-1.02 0.14
2% Gel 0.75 0.52-1.05 0.02
Table 2. Risk reduction of intratracheal lidocaine
OR* 95% CI* P-Value
ENT Service Line* 3.72 2.47-5.62 <0.01
Multiple Positions 3.01 2.27-3.99 <0.01
Succinylcholine Use 3.28 1.90-5.68 <0.01
Succ + Roc* 0.35 0.17-0.73 0.005











Figure 2. Rates of intratracheal lidocaine 
administration and POST by modality
*OR: Odds ratio; 95% Confidence Interval; ENT: Ear nose and throat; Succinylcholine & 
Rocuronium administration reduced odds of  POST
